chemie.pr-Pan-European Research Reveals Majority of Osteoporosis Patients not ...
Pan-European Research Reveals Majority of Osteoporosis Patients not Receiving Recommended Combination of Calcium and Vitamin D With Treatment
Pan-European Research Reveals Majority of Osteoporosis Patients not Receiving Recommended Combination of Calcium and Vitamin D With Treatment
15.09.2008 10:40:06
Procter& Gamble: Geneva (ots/PRNewswire) - - Study Highlights Underlying Reasons for why Patients are Missing Their Supplementation GENEVA, September 15 /PRNewswire/ -- New research published today at the annual meeting of the American Society for Bone and Mineral Research (ASBMR), Montréal, Canada, reveals that less than half (43%) of patients in Europe with osteoporosis are claiming to take both calcium and vitamin D ...
Lesen Sie hier weiter... |
Drucken |
PDF
Ähnliche Artikel
- European Medicines Agency (EMEA) Approves Relistor(TM) The First-in-Class Treatment of Opioid-Induced Constipation (OIC) in Advanced-Illness Patients
- European Approval for Roche's Pegasys Personalises Treatment for a Subgroup of Hepatitis C Patients: Chance for Cure With Only Four Months of Treatment
- European Commission Approval of New Indication for Roche's Pegasys(R) (peginterferon alfa-2a) Offers Hepatitis C Patients a Second Chance for a Cure
- Global Study Reveals Differences in Standard of Care for Osteoporosis Across the World
- New Research Reveals That Mycamine(R) is an Effective Treatment in Children, Young Babies and Premature Infants
- Erbitux Significantly Prolongs Survival in 1st-Line Treatment of Non-Small Cell Lung Cancer
- Bimatoprost / Timolol Fixed Combination Therapy Demonstrates Significantly Better IOP Control Over 12 Hours Compared to Latanoprost / Timolol Combination
- New Data Confirms Avastin (R) as the Only Biologic to Demonstrate Overall Survival When Used First-Line in Metastatic Colorectal Cancer Patients With K-RAS (Wild-Type) Gene Status
- Bowel Cancer Patients Live Longer Taking Xeloda
- INTELENCE(TM) (Etravirine) Receives Marketing Authorisation in the European Union for HIV Combination Therapy
Pan-European Research Reveals Majority of Osteoporosis Patients not ...
Pan-European Research Reveals Majority of Osteoporosis Patients not Receiving Recommended Combination of Calcium and Vitamin D With Treatment.Procter & Gamble:
Bankkaufmann - News
Pan-European Research Reveals Majority of Osteoporosis Patients not Receiving Recommended Combination of Calcium and Vitamin D With Treatment
Presseportal: Procter & Gamble - Pampers wird 30
Pan-European Research Reveals Majority of Osteoporosis Patients not Receiving Recommended Combination of Calcium and Vitamin D With Treatment
Presseportal.de - Procter & Gamble
Pan-European Research Reveals Majority of Osteoporosis Patients not Receiving Recommended Combination of Calcium and Vitamin D With Treatment